These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 751903)
1. Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factors. Nikoskelainen J; Stevens DA; Neel EU; Isenberg RA; Miller RG; Halpern JW; Gelpi AP IARC Sci Publ (1971); 1978; (24 Pt 2):699-709. PubMed ID: 751903 [TBL] [Abstract][Full Text] [Related]
2. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224 [TBL] [Abstract][Full Text] [Related]
3. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens. Periman P; Levine PH; Ablashi DV; Royston I Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544 [TBL] [Abstract][Full Text] [Related]
4. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G; Straus S; Henle W; Pike SE; Blaese RM J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte reactivity in infectious mononucleosis. ten Napel CH; The TH J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602 [TBL] [Abstract][Full Text] [Related]
6. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A; J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261 [TBL] [Abstract][Full Text] [Related]
9. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M; Myc A; Matej H; Rudzka L Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340 [TBL] [Abstract][Full Text] [Related]
10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis. Strang G; Rickinson AB Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688 [TBL] [Abstract][Full Text] [Related]
11. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis]. Imai S Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132 [TBL] [Abstract][Full Text] [Related]
12. Suppression of spontaneous in vitro transformation of autologous leukocytes by plasma from convalescent and postconvalescent infectious mononucleosis patients. Chang RS; Spina CA J Natl Cancer Inst; 1975 Oct; 55(4):803-5. PubMed ID: 171425 [TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. Royston I; Sullivan JL; Periman PO; Perlin E N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. Tomkinson BE; Maziarz R; Sullivan JL J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449 [TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. Jondal M Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222 [TBL] [Abstract][Full Text] [Related]